SMTL ID : 7rby.2 (1 other biounit)

Crystal structure of Nanobody nb112 and SARS-CoV-2 RBD

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.82 Å

Oligo State

hetero-1-1-mer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 3 residues within 4Å: Chain A: G.11, N.15, V.39 1 PLIP interactions: 1 interactions with chain A Water bridges: A:N.15

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 1 residues within 4Å: Chain A: P.171 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Esparza, T.J. et al., Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19. Mabs

Release Date

2022-03-23

Peptides

Spike protein S1: A
Ilama-isolated nanobody NIH-CoV nb-112 specific to SARS-CoV-2 RBD: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Spike protein S1

Ilama-isolated nanobody NIH-CoV nb-112 specific to SARS-CoV-2 RBD

Related Entries With Identical Sequence